An internationally recognized healthcare research institution and medical center engaged CRA to assist it in preparing for negotiations with other treatment facility operators for the license of a proton treatment patent portfolio. As part of its work, CRA identified potential worldwide licensees, developed detailed financial models from the client’s and licensee’s perspective, and provided a negotiation preparation package for negotiations with potential licensees that included proposed financial term sheets under different license structures and sensitivity analyses.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...